Algiax Pharmaceuticals
Algiax Pharmaceuticals GmbH is an independent biotechnology company that was established in April 2011. It is dedicated to the discovery and development of innovative products to treat diseases with a high unmet medical need. In the field of nervous system disease, Algiax has a strong focus on neuropathic pain and acute spinal cord injury. Algiax’ lead candidate AP-325 is in clinical development for the treatment of neuropathic pain. A selection of new chemical entities (AP-4 & AP-8) is in preclinical development for the treatment of Diabetes Type 1. Algiax’ strategy is to develop its drug candidates up to a Clinical Phase stage and out-license them to pharmaceutical and biotech companies for further clinical development and market authorisation.
7-day free trial · no credit card
Verified contacts
2
available on Kipplo
LinkedIn employees
5
1 to 10 range
Open roles
—
no listings
Distinct roles
2
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 2 verified contacts at Algiax Pharmaceuticals
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
2 contacts with verified email or phone · masked until revealed.
Showing 1 of 2 verified contacts
Top roles at Algiax Pharmaceuticals
2 distinct titles indexed · top 2 shown.
- 1chief scientific officer
- 1member of the advisory board
Sign up to unlock all 2 contacts at Algiax Pharmaceuticals
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 2 verified contacts at Algiax Pharmaceuticals
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.